A double-blind, placebo controlled, randomised, comparative 2-way crossover study to determine the effect of concomitant treatment with an androgen on sexual arousability and the vascular component of the sexual arousal response during self-induced erotic fantasy and visual stimulation in women using oral contraception.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Prasterone (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- Acronyms ARC-AMC
- Sponsors Pantarhei Bioscience
- 07 Aug 2012 Actual initiation date (March 2007) added as reported by European Clinical Trials Database record.
- 02 Jan 2010 New trial record